Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia. The company offers Felix system, a device separates sperm from raw semen by electrophoresis process and size exclusion membranes. It also provides RoXsta, a rapid in vitro antioxidant assessment; and AI-Port, an ambient temperature semen transport device for artificial insemination in animals. In addition, the company develops ambient temperature storage product for human sperm; and a medium for human sperm isolation, fertilisation and cryopreservation. Memphasys Limited was incorporated in 2006 and is based in Homebush, Australia.
Metrics to compare | MEM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEMPeersSector | |
---|---|---|---|---|
P/E Ratio | −1.8x | −2.5x | −0.7x | |
PEG Ratio | −0.05 | −0.10 | 0.00 | |
Price/Book | 2.1x | 3.9x | 2.6x | |
Price / LTM Sales | 17.0x | 7.7x | 3.4x | |
Upside (Analyst Target) | - | 147.8% | 37.8% | |
Fair Value Upside | Unlock | 5.0% | 5.5% | Unlock |